↓ Skip to main content

Applying post-neoadjuvant pathologic stage as prognostic tool in esophageal squamous cell carcinoma

Overview of attention for article published in Frontiers in oncology, November 2022
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
3 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Applying post-neoadjuvant pathologic stage as prognostic tool in esophageal squamous cell carcinoma
Published in
Frontiers in oncology, November 2022
DOI 10.3389/fonc.2022.998238
Pubmed ID
Authors

Weiming Han, Wei Deng, Qifeng Wang, Wenjie Ni, Chen Li, Zongmei Zhou, Jun Liang, Dongfu Chen, Qinfu Feng, Nan Bi, Tao Zhang, Xin Wang, Lei Deng, Wenqing Wang, Wenyang Liu, Jianyang Wang, Qi Xue, Yousheng Mao, Xiangyang Liu, Dekang Fang, Jian Li, Dali Wang, Jun Zhao, Zefen Xiao

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 3 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 3 100%

Demographic breakdown

Readers by professional status Count As %
Librarian 1 33%
Unknown 2 67%
Readers by discipline Count As %
Medicine and Dentistry 1 33%
Unknown 2 67%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 November 2022.
All research outputs
#21,493,958
of 26,370,291 outputs
Outputs from Frontiers in oncology
#11,880
of 23,018 outputs
Outputs of similar age
#331,460
of 446,782 outputs
Outputs of similar age from Frontiers in oncology
#1,093
of 1,691 outputs
Altmetric has tracked 26,370,291 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 23,018 research outputs from this source. They receive a mean Attention Score of 3.2. This one is in the 27th percentile – i.e., 27% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 446,782 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,691 others from the same source and published within six weeks on either side of this one. This one is in the 6th percentile – i.e., 6% of its contemporaries scored the same or lower than it.